Evidence map›Paper›PMID 29117439›Full record

ArticleJournal of advanced nursing2018

The Female Self-Advocacy in Cancer Survivorship Scale: A validation study.

Teresa L Hagan, Susan M Cohen, Margaret Q Rosenzweig, Kristin Zorn, Clement A Stone, Heidi S Donovan

Abstract readValidation Study
In one paragraph

Article in Journal of advanced nursing, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 33 citations in OpenAlex.

  1. Feasibility of a Remote Patient Video Education Intervention to Improve Care Coordination for Rural Cancer Patients.Journal of cancer education : the official journal of the American Association for Cancer Education · 2025
    Trial
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Gender Differences in Self-Advocacy Among Cancer Survivors: How Women and Men Vary in How They Learn to Engage in Decision-Making and Social Support.Journal of cancer education : the official journal of the American Association for Cancer Education · 2025
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Teresa L HaganCenter for Psychiatric Oncology and Behavioral Sciences, Massachusetts General Hospital/Harvard Medical School, Boston, MA, USA.ORCID http://orcid.org/0000-0001-7403-7314
Susan M CohenDepartment of Health Promotion and Development, University of Pittsburgh School of Nursing, Pittsburgh, PA, USA.ORCID http://orcid.org/0000-0002-3860-4681
Margaret Q RosenzweigDepartment of Acute and Tertiary Care, University of Pittsburgh School of Nursing, Pittsburgh, PA, USA.ORCID http://orcid.org/0000-0003-2276-9673
Kristin ZornDepartment of Obstetrics & Gynecology, University of Arkansas for Medical Sciences, Little Rock, AR, USA.ORCID http://orcid.org/0000-0003-2143-8979
Clement A StoneDepartment of Psychology in Education, University of Pittsburgh School of Education, Pittsburgh, PA, USA.
Heidi S DonovanDepartment of Health & Community Systems, University of Pittsburgh School of Nursing, Pittsburgh, PA, USA.ORCID http://orcid.org/0000-0002-4889-8644
University of Pittsburgh · USHarvard University · USUniversity of Arkansas for Medical Sciences · US

Funding

Development and Validation of a Measure of Self-Advocacy in Female Cancer SurvivoF31NR014066 · NINR · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI THOMAS, TERESA HAGAN · 2013 to 2015
$90k
NINR NIH HHS F31 NR014066
6 · The paper itself

Abstract

aimTo develop and psychometrically test the validity of the Female Self-Advocacy in Cancer Survivorship Scale.

backgroundFemale cancer survivors need to self-advocate to overcome challenges associated with cancer yet no valid measure of self-advocacy exists.

designInstrument development. Mixed-mode cross-sectional survey design.

participantsWe recruited adult females (18+ years; N = 317) with a history of invasive cancer from local and national tumour registries and advocacy organizations to complete online or paper questionnaires.

methodsBetween July 2014 - March 2015 to evaluate the construct validity based on evidence of the scale's: (1) internal structure consistent with the underlying model of self-advocacy; (2) sensitivity to differences between groups known to differ in self-advocacy skills; (3) relationships between self-advocacy and key potential predictors (openness and conscientiousness; information engagement; social support) and outcomes (symptom burden and healthcare utilization); (4) relationships between self-advocacy and related concepts (patient activation; self-advocacy within another patient population); and (5) relationships between self-advocacy and criterion measures. Analyses included an exploratory factor analysis, t tests, and bivariate correlations using validated, reliable measures for constructs.

resultsEvidence from all five hypotheses supported the construct validity of the Female Self-Advocacy in Cancer Survivorship Scale. The factor analysis confirmed the three underlying dimensions of self-advocacy resulting in a 20-item measure with strong internal consistency that explained almost half of response variance.

conclusionThe Female Self-Advocacy in Cancer Survivorship Scale is a valid, reliable measure of how well adult female cancer survivors can get their needs met in the face of adversity.

Indexed as

Self EfficacyAdultAgedAged, 80 and overCancer SurvivorsCross-Sectional StudiesFemaleHumansMiddle AgedNeoplasmsPsychometricsReproducibility of ResultsSurveys and QuestionnairesUnited Statesinstrument developmentneoplasmnursingpatient advocacypower

Identifiers

PMID29117439
PMCPMC5844819
OpenAlexW2767318397

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.